Kaempferol suppresses lipid accumulation in macrophages through the downregulation of cluster of differentiation 36 and the upregulation of scavenger receptor class B type I and ATP-binding cassette transporters A1 and G1

Li,Xiu-Ying; Kong,Ling-Xi; Li,Juan; He,Hai-Xia; Zhou,Yuan-Da

doi:10.3892/ijmm.2012.1204

Kaempferol suppresses lipid accumulation in macrophages through the downregulation of cluster of differentiation 36 and the upregulation of scavenger receptor class B type I and ATP-binding cassette transporters A1 and G1

Authors:
- Xiu-Ying Li
- Ling-Xi Kong
- Juan Li
- Hai-Xia He
- Yuan-Da Zhou
View Affiliations

Affiliations: Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China
Published online on: December 5, 2012 https://doi.org/10.3892/ijmm.2012.1204
Pages: 331-338

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The accumulation of foam cells in atherosclerotic lesions is a hallmark of early-stage atherosclerosis. Kaempferol has been shown to inhibit oxidized low-density lipoprotein (oxLDL) uptake by macrophages; however, the underlying molecular mechanisms are not yet fully investigated. In this study, we shown that treatment with kaempferol markedly suppresses oxLDL-induced macrophage foam cell formation, which occurs due to a decrease in lipid accumulation and an increase in cholesterol efflux from THP-1-derived macrophages. Additionally, the kaempferol treatment of macrophages led to the downregulation of cluster of differentiation 36 (CD36) protein levels, the upregulation of ATP-binding cassette (ABC) transporter A1 (ABCA1), scavenger receptor class B type I (SR-BI) and ABCG1 protein levels, while no effects on scavenger receptor A (SR-A) expression were observed. Kaempferol had similar effects on the mRNA and protein expression of ABCA1, SR-BI, SR-A, CD36 and ABCG1. The reduced CD36 expression following kaempferol treatment involved the inhibition of c-Jun-activator protein-1 (AP-1) nuclear translocation. The inhibition of AP-1 using the inhibitor, SP600125, confirmed this involvement, as the AP-1 inhibition significantly augmented the kaempferol-induced reduction in CD36 expression. Accordingly, the kaempferol-mediated suppression of lipid accumulation in macrophages was also augmented by SP600125. The increased expression of ABCA1, SR-BI and ABCG1 following kaempferol treatment was accompanied by the enhanced protein expression of heme oxygenase-1 (HO-1). This increase was reversed following the knockdown of the HO-1 gene using small hairpin RNA (shRNA). Moreover, the kaempferol-mediated attenuation of lipid accumulation and the promotion of cholesterol efflux was also inhibited by HO-1 shRNA. In conclusion, the c-Jun-AP‑1-dependent downregulation of CD36 and the HO-1-dependent upregulation of ABCG1, SR-BI and ABCA1 may mediate the beneficial effects of kaempferol on foam cell formation.

View Figures

View References

1.	Tsimikas S, Miyanohara A, Hartvigsen K, et al: Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. J Am Coll Cardiol. 58:1715–1727. 2011. View Article : Google Scholar : PubMed/NCBI
2.	Sung HJ, Kim J, Kim Y, Jang SW and Ko J: N-acetyl cysteine suppresses the foam cell formation that is induced by oxidized low density lipoprotein via regulation of gene expression. Mol Biol Rep. 39:3001–3007. 2012. View Article : Google Scholar : PubMed/NCBI
3.	Li AC and Glass CK: The macrophage foam cell as a target for therapeutic intervention. Nat Med. 8:1235–1242. 2002. View Article : Google Scholar : PubMed/NCBI
4.	Kleemann R, Zadelaar S and Kooistra T: Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res. 79:360–376. 2008. View Article : Google Scholar : PubMed/NCBI
5.	Hrboticky N, Draude G, Hapfelmeier G, Lorenz R and Weber PC: Lovastatin decreases the receptor-mediated degradation of acetylated and oxidized LDLs in human blood monocytes during the early stage of differentiation into macrophages. Arterioscler Thromb Vasc Biol. 19:1267–1275. 1999. View Article : Google Scholar : PubMed/NCBI
6.	Wang X and Rader DJ: Molecular regulation of macrophage reverse cholesterol transport. Curr Opin Cardiol. 22:368–372. 2007. View Article : Google Scholar : PubMed/NCBI
7.	Cuchel M and Rader DJ: Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation. 113:2548–2555. 2006. View Article : Google Scholar : PubMed/NCBI
8.	Chirumbolo S: The role of quercetin, flavonols and flavones in modulating inflammatory cell function. Inflamm Allergy Drug Targets. 9:263–285. 2010. View Article : Google Scholar : PubMed/NCBI
9.	González-Gallego J, Sánchez-Campos S and Tuñón MJ: Anti-inflammatory properties of dietary flavonoids. Nutr Hosp. 22:287–293. 2007.
10.	Calderón-Montaño JM, Burgos-Morón E, Pérez-Guerrero C and López-Lázaro M: A review on the dietary flavonoid kaempferol. Mini Rev Med Chem. 11:298–344. 2011.PubMed/NCBI
11.	Park MY, Ji GE and Sung MK: Dietary kaempferol suppresses inflammation of dextran sulfate sodium-induced colitis in mice. Dig Dis Sci. 57:355–363. 2012. View Article : Google Scholar : PubMed/NCBI
12.	Xiao HB, Lu XY, Sun ZL and Zhang HB: Kaempferol regulates OPN-CD44 pathway to inhibit the atherogenesis of apolipoprotein E deficient mice. Toxicol Appl Pharmacol. 257:405–411. 2011. View Article : Google Scholar : PubMed/NCBI
13.	Hong JT, Yen JH, Wang L, Lo YH, Chen ZT and Wu MJ: Regulation of heme oxygenase-1 expression and MAPK pathways in response to kaempferol and rhamnocitrin in PC12 cells. Toxicol Appl Pharmacol. 237:59–68. 2009. View Article : Google Scholar : PubMed/NCBI
14.	Chen CC, Chow MP, Huang WC, Lin YC and Chang YJ: Flavonoids inhibit tumor necrosis factor-alpha-induced upregulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships. Mol Pharmacol. 66:683–693. 2004.
15.	Li XY, He JL, Liu HT, Li WM and Yu C: Tetramethylpyrazine suppresses interleukin-8 expression in LPS-stimulated human umbilical vein endothelial cell by blocking ERK, p38 and nuclear factor-kappaB signaling pathways. J Ethnopharmacol. 125:83–89. 2009. View Article : Google Scholar
16.	Kalayoglu MV, Hoerneman B, LaVerda D, Morrison SG, Morrison RP and Byrne GI: Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis. 180:780–790. 1999. View Article : Google Scholar : PubMed/NCBI
17.	Cheng LC, Su KH, Kou YR, et al: α-Lipoic acid ameliorates foam cell formation via liver X receptor α-dependent upregulation of ATP-binding cassette transporters A1 and G1. Free Radic Biol Med. 50:47–54. 2011.
18.	Tsai JY, Su KH, Shyue SK, et al: EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1. Cardiovasc Res. 88:415–423. 2010. View Article : Google Scholar : PubMed/NCBI
19.	Lim H and Kim HP: Inhibition of mammalian collagenase, matrix metalloproteinase-1, by naturally-occurring flavonoids. Planta Med. 73:1267–1274. 2007. View Article : Google Scholar : PubMed/NCBI
20.	Crespo I, García-Mediavilla MV, Gutiérrez B, Sánchez-Campos S, Tuñón MJ and González-Gallego J: A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells. Br J Nutr. 100:968–976. 2008. View Article : Google Scholar : PubMed/NCBI
21.	Abeywardena MY and Head RJ: Dietary polyunsaturated fatty acid and antioxidant modulation of vascular dysfunction in the spontaneously hypertensive rat. Prostaglandins Leukot Essent Fatty Acids. 65:91–97. 2001. View Article : Google Scholar : PubMed/NCBI
22.	Mekhora C, Muangnoi C, Chingsuwanrote P, Dawilai S, Svasti S, Chasri K and Tuntipopipat S: Eryngium foetidum suppresses inflammatory mediators produced by macrophages. Asian Pac J Cancer Prev. 13:653–664. 2012. View Article : Google Scholar : PubMed/NCBI
23.	Tu YC, Lian TW, Yen JH, Chen ZT and Wu MJ: Antiatherogenic effects of kaempferol and rhamnocitrin. J Agric Food Chem. 28:9969–9976. 2007.
24.	Witztum JL: You are right too! J Clin Invest. 115:2072–2075. 2005.
25.	Kunjathoor VV, Febbraio M, Podrez EA, et al: Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem. 277:49982–49988. 2002. View Article : Google Scholar
26.	Katayama I, Hotokezaka Y, Matsuyama T, Sumi T and Nakamura T: Ionizing radiation induces macrophage foam cell formation and aggregation through JNK-dependent activation of CD36 scavenger receptors. Int J Radiat Oncol Biol Phys. 70:835–846. 2008. View Article : Google Scholar : PubMed/NCBI
27.	Oh J, Weng S, Felton SK, et al: 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation. 120:687–698. 2009. View Article : Google Scholar : PubMed/NCBI
28.	Duh PD, Hsiao WC and Wang BS: An aqueous extract of Welsh onion green leaves increase ABCA1 and SR-BI expression in macrophage RAW 264.7 cells. Food Chemistry. 107:1029–1038. 2008. View Article : Google Scholar
29.	Lu KY, Ching LC, Su KH, et al: Erythropoietin suppresses the formation of macrophage foam cells: role of liver X receptor alpha. Circulation. 121:1828–1837. 2010. View Article : Google Scholar : PubMed/NCBI
30.	Chang YC, Lee TS and Chiang AN: Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages. J Lipid Res. 53:1840–1850. 2012. View Article : Google Scholar : PubMed/NCBI
31.	Gao J, Xu Y, Yang Y, et al: Identification of upregulators of human ATP-binding cassette transporter A1 via high-throughput screening of a synthetic and natural compound library. J Biomol Screen. 13:648–656. 2008. View Article : Google Scholar : PubMed/NCBI
32.	Ishikawa K, Sugawara D, Wang Xp, Suzuki K, Itabe H, Maruyama Y and Lusis AJ: Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ Res. 88:506–512. 2001. View Article : Google Scholar : PubMed/NCBI
33.	Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK and Chau LY: J Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation. 104:1519–1525. 2001. View Article : Google Scholar : PubMed/NCBI
34.	Idriss NK, Blann AD and Lip GY: Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol. 52:971–978. 2008. View Article : Google Scholar : PubMed/NCBI